Your browser doesn't support javascript.
loading
CD19 epitope masking by tafasitamab leads to delays in subsequent use of CD19 CAR T-cell therapy in two patients with aggressive mature B-cell lymphomas.
Fitzgerald, Kelly N; Quesada, Andres E; von Keudell, Gottfried; Raj, Sandeep; Lewis, Natasha E; Dogan, Ahmet; Salles, Gilles; Palomba, M Lia.
Afiliación
  • Fitzgerald KN; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Quesada AE; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • von Keudell G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Raj S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lewis NE; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Dogan A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Salles G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Palomba ML; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Leuk Lymphoma ; 63(3): 751-754, 2022 03.
Article en En | MEDLINE | ID: mdl-34949132
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos